Skip to main content
OPKO HEALTH, INC. logo

OPKO HEALTH, INC. — Investor Relations & Filings

Ticker · OPK US Manufacturing
Filings indexed 2,253 across all filing types
Latest filing 2026-03-20 Director's Dealing
Country US United States of America
Listing US OPK

About OPKO HEALTH, INC.

https://www.opko.com/

OPKO Health, Inc. is a diversified healthcare company operating in two primary segments: diagnostics and pharmaceuticals. The diagnostics division includes BioReference Laboratories, one of the largest full-service clinical laboratories in the United States, offering a wide range of testing services. The pharmaceuticals division focuses on developing and commercializing novel therapies for serious diseases. Key products include NGENLA™, a long-acting human growth hormone for pediatric patients, and RAYALDEE® for secondary hyperparathyroidism in adults with chronic kidney disease. The company's research is centered on advancing multispecific therapies for conditions such as cancers and infectious diseases, often through strategic partnerships with other leading global organizations.

Recent filings

Filing Released Lang Actions
4 - OPKO HEALTH, INC. (0000944809) (Issuer)
Director's Dealing
2026-03-20 English
4 - OPKO HEALTH, INC. (0000944809) (Issuer)
Director's Dealing
2026-03-20 English
3 - OPKO HEALTH, INC. (0000944809) (Issuer)
Director's Dealing
2026-03-20 English
8-K - OPKO HEALTH, INC. (0000944809) (Filer)
Regulatory Filings
2026-03-19 English
10-K - OPKO HEALTH, INC. (0000944809) (Filer)
Annual Report FY 2025
2026-02-26 English
8-K - OPKO HEALTH, INC. (0000944809) (Filer)
Regulatory Filings
2026-02-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.